Jeffrey Meldrum, a professor of anatomy and anthropology at Idaho State University in Pocatello, liked to begin his scholarly talks with a long and fastidious primer on human evolution before finally ...

The Orbitrap Exploris EFOX Mass Detector targets environmental and food safety labs for efficient contaminant monitoring, focusing on PFAS, pesticides, and organic pollutants. Thermo Fisher’s Orbitrap ...

In the last three months, 8 analysts have published ratings on Thermo Fisher Scientific (NYSE:TMO), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a ...

Thermo Fisher Scientific stock has rebounded strongly as tariff and policy fears proved overstated, with shares up 30% since the prior low. Thermo raised 2025 revenue and EPS guidance, driven by sales ...

Roth Capital explains why CRWV deal collapse will be constructive for CORZ stock. Core Scientific shareholders are expected to vote against that deal on October 30. Core Scientific shares are already ...

Oct 22 (Reuters) - Thermo Fisher Scientific (TMO.N), opens new tab raised its annual profit and revenue forecasts on Wednesday, as the medical equipment maker expects robust demand for lab tools and ...

Thermo Fisher recorded higher third-quarter sales on the back of growth in its life sciences business. The scientific services company reported net income of $1.62 billion, or $4.27 a share, compared ...

Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions. Thermo Fisher Scientific Inc. (NYSE: TMO ...

Third quarter revenue grew 5% to $11.12 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter. Third quarter adjusted EPS grew 10% to $5.79.

Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump in the third quarter. The company, which has business lines ranging from ...

WALTHAM, Mass. –The ardor for Thermo Fisher Scientific stock appears to have returned to more normal levels. After reporting second quarter results in July, the company’s shares jumped more than 10%.